Im actually really worried about that, Hwang says
I always tell patients we dont know exactly what itll do in you
Tirzepatide, a dual GIPR/GLP-1R agonist, has shown antitumor effects in models of EC and colorectal cancer (CRC) (69), whereas retatrutide, a triple GIPR/GLP-1R/GCGR agonist, has shown antitumor activity in pancreatic and lung cancer models (70)
The intensity of these reactions depends on your genetic predisposition to peptide sensitivity, baseline digestive function, and how rapidly your dose increases
And at $249/month, the ongoing medication cost sits on the higher end of the market
It further delays gastric emptying and enhances satiety, potentially offering even greater weight loss when paired with GLP-1 in Charleston